News and Trends 22 Dec 2022
First CAR-T technology trial for patients with T-cell leukemia subtype authorized
The Spanish Agency of Medicines and Medical Products (AEMPS) has approved the CARxALL clinical trial led by the company OneChain Immunotherapeutics (OCI). It will be the world’s first trial with…